Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cost Effective Treatment for Dually Diagnosed Homeless
Brief Summary: This randomized controlled trial examined whether an abbreviated treatment using abstinence contingency management for housing and work/training (CM, n=103) with cocaine dependent, non-psychotic, dually diagnosed homeless persons, would show non-inferior outcomes compared to the full treatment (CM+, n=103). It was hypothesized that CM+ would show superior abstinence and retention outcomes, but that CM, with components derived from previously effective behavioral day treatment, would obtain non-inferior outcomes, defined as 75% or more of those observed for the full treatment (CM+) during active treatment months 1-6. The CM+ included all CM components but added behavioral day treatment that included voucher reinforcement of $7.50-15.00, for objective weekly therapeutic goal attainment in five domains of functioning: drug dependence, homelessness, unemployment, non-drug related recreational activities, and behavioral, health, or mental health problems. Abstinence was assessed by observed urine specimen collection and weekly testing weeks 1-52, and randomly, bi-monthly for months 13-18. Abstinence, homelessness, employment and other outcomes were also assessed at baseline, 2, 6, 12, and 18 months.


Options:
A: Arm Label: Standard; Type: OTHER; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing | Arm Label: SI/WWE; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam | Arm Label: SI/WWE/PD; Type: EXPERIMENTAL; Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing, Behavioral: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention | Intervention Type: BEHAVIORAL; Name: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing; Assigned to Arm(s): SI/WWE, SI/WWE/PD, Standard | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam; Assigned to Arm(s): SI/WWE | Intervention Type: BEHAVIORAL; Name: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention; Assigned to Arm(s): SI/WWE/PD
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Disulfiram; Type: ACTIVE_COMPARATOR; Interventions: Drug: disulfiram | Arm Label: Placebo plus Contingency Management; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo plus Contingency Management | Arm Label: Disulfiram plus Contingency Management; Type: ACTIVE_COMPARATOR; Interventions: Drug: Disulfiram plus Contingency Management | Intervention Type: DRUG; Name: disulfiram; Assigned to Arm(s): Disulfiram | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: BEHAVIORAL; Name: Placebo plus Contingency Management; Assigned to Arm(s): Placebo plus Contingency Management | Intervention Type: DRUG; Name: Disulfiram plus Contingency Management; Assigned to Arm(s): Disulfiram plus Contingency Management
C: Intervention Type: BEHAVIORAL; Name: contingency management and behavioral day treatment; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Treatment as usual (TAU) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Other: Treatment as usual (TAU), Behavioral: CBT for CBT | Intervention Type: OTHER; Name: Treatment as usual (TAU); Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: CBT for CBT; Assigned to Arm(s): 2

Answer: C